The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Add Yahoo as a preferred source to see more of our stories on Google. The changes to Insulet's Omnipod algorithm are intended to give users greater control over their insulin management. Image credit: ...

Add Yahoo as a preferred source to see more of our stories on Google. The update offers healthcare professionals and patients six target glucose options ranging from 100mg/dL to 150mg/dL. Credit: ...

Insulet Corporation was recently added to both the Russell 2500 Index and the Russell 2500 Growth Benchmark, and earlier this week appointed former IDEXX Laboratories chief executive Jonathan (“Jay”) ...

ACTON, Mass., June 03, 2026--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, ...

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and ...

The Omnipod 5 with an iPhone [Image courtesy of Insulet] Insulet (Nasdaq:PODD) announced today that it launched its Omnipod 5 ...

Adults with type 2 diabetes achieved higher time in range with the next-generation Omnipod 6 automated insulin delivery ...

In early June 2026, Insulet began rolling out FDA-cleared algorithm enhancements to its Omnipod 5 Automated Insulin Delivery System in the U.S., adding a 100 mg/dL target option and new compatibility ...

(RTTNews) - Insulet (PODD) announced it has received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. The new 100 mg/dL Target Glucose expands ...